1-20 of 265
cardiovascular system
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression

José M. Rodriguez-Valadez, Malak Tahsin, Kirsten E. Fleischmann, Umesh Masharani, Joseph Yeboah, Meyeon Park, Lihua Li, Ellerie Weber, Yan Li, Asem Berkalieva, Wendy Max, M.G. Myriam Hunink, Bart S. Ferket
Journal: Diabetes Care
Diabetes Care 2023;46(6):1300–1310
DOI: https://doi.org/10.2337/dc22-0772
Published: 23 May 2023
View article titled, Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression
Open the PDF for Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression in another window
Journal Articles

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study

Huan Wang, Ruth L.M. Cordiner, Yu Huang, Louise Donnelly, Simona Hapca, Andrew Collier, John McKnight, Brian Kennon, Fraser Gibb, Paul McKeigue, Sarah H. Wild, Helen Colhoun, John Chalmers, John Petrie, Naveed Sattar, Thomas MacDonald, Rory J. McCrimmon, Daniel R. Morales, Ewan R. Pearson, Scottish Diabetes Research Network Epidemiology Group , Luke Blackbourn, Scott Cunningham, Fraser Gibb, Graham Leese, Robert Lindsay, David McAllister, Stuart McGurnaghan, Sam Philip
Journal: Diabetes Care
Diabetes Care 2023;46(5):967–977
DOI: https://doi.org/10.2337/dc22-1238
Published: 21 March 2023
View article titled, Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
Open the PDF for Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study in another window
Journal Articles

Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995–2019: A Population-Based Study

Baiju R. Shah, Peter C. Austin, Calvin Ke, Lorraine L. Lipscombe, Alanna Weisman, Gillian L. Booth
Journal: Diabetes Care
Diabetes Care 2023;46(4):751–756
DOI: https://doi.org/10.2337/dc22-1936
Published: 31 January 2023
View article titled, Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995–2019: A Population-Based Study
Open the PDF for Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995–2019: A Population-Based Study in another window
Journal Articles

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

Jelle M. Beernink, Frederik Persson, Niels Jongs, Gozewijn D. Laverman, Glenn M. Chertow, John J.V. McMurray, Anna Maria Langkilde, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2023;46(3):602–607
DOI: https://doi.org/10.2337/dc22-1514
Published: 20 January 2023
View article titled, Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
Open the PDF for Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study in another window
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Sandeep R. Das, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Mikhail Kosiborod, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S158–S190
DOI: https://doi.org/10.2337/dc23-S010
Published: 12 December 2022
View article titled, 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
Open the PDF for 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 in another window
Journal Articles

Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study

Jonas Brinck, Emil Hagström, Jonatan Nåtman, Stefan Franzén, Katarina Eeg-Olofsson, David Nathanson, Björn Eliasson
Journal: Diabetes Care
Diabetes Care 2022;45(12):3040–3049
DOI: https://doi.org/10.2337/dc22-1025
Published: 01 December 2022
View article titled, Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
Open the PDF for Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study in another window
Journal Articles

Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease

Patrik Smidtslund, Fanny Jansson Sigfrids, Anni Ylinen, Nina Elonen, Valma Harjutsalo, Per-Henrik Groop, Lena M. Thorn
Journal: Diabetes Care
Diabetes Care 2023;46(1):197–205
DOI: https://doi.org/10.2337/dc22-1586
Published: 18 November 2022
View article titled, Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease
Open the PDF for Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease in another window
Journal Articles

Long-term Effect of Lifestyle Interventions on the Cardiovascular and All-Cause Mortality of Subjects With Prediabetes and Type 2 Diabetes: A Systematic Review and Meta-analysis

Kelly P. Zucatti, Paula P. Teixeira, Laura F. Wayerbacher, Giovana F. Piccoli, Poliana E. Correia, Natasha K.O. Fonseca, Karla S. Moresco, Bruno A. Guerra, Michelle G. Maduré, Laura P. Farenzena, Anize D. Frankenberg, Elisa Brietzke, Bruno Halpern, Oscar Franco, Verônica Colpani, Fernando Gerchman
Journal: Diabetes Care
Diabetes Care 2022;45(11):2787–2795
DOI: https://doi.org/10.2337/dc22-0642
Published: 25 October 2022
View article titled, Long-term Effect of Lifestyle Interventions on the Cardiovascular and All-Cause Mortality of Subjects With Prediabetes and Type 2 Diabetes: A Systematic Review and Meta-analysis
Open the PDF for Long-term Effect of Lifestyle Interventions on the Cardiovascular and All-Cause Mortality of Subjects With Prediabetes and Type 2 Diabetes: A Systematic Review and Meta-analysis in another window
Journal Articles

Bernard Zinman: A Canadian Clinician Scientist Changing the Management of Diabetes

Daniel J. Drucker
Journal: Diabetes Care
Diabetes Care 2022;45(8):1709–1714
DOI: https://doi.org/10.2337/dci22-0017
Published: 26 July 2022
View article titled, Bernard Zinman: A Canadian Clinician Scientist Changing the Management of Diabetes
Open the PDF for Bernard Zinman: A Canadian Clinician Scientist Changing the Management of Diabetes in another window
Journal Articles

Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)

Ele Ferrannini, Simona Baldi, Tiziana Scozzaro, Vasilis Tsimihodimos, Fisseha Tesfaye, Wayne Shaw, Norman Rosenthal, Gemma A. Figtree, Bruce Neal, Kenneth W. Mahaffey, Vlado Perkovic, Michael K. Hansen
Journal: Diabetes Care
Diabetes Care 2022;45(8):1893–1899
DOI: https://doi.org/10.2337/dc21-2398
Published: 26 July 2022
View article titled, Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)
Open the PDF for Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS) in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study

Hao-Chih Chang, Tzu-Ting Kuo, Yun-Yu Chen, Yenn-Jiang Lin, Hung-Yu Chang, Chung-Lieh Hung, Fa-Po Chung
Journal: Diabetes Care
Diabetes Care 2022;45(9):129–130
DOI: https://doi.org/10.2337/dc22-0938
Published: 15 July 2022
View article titled, Sodium–Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study in another window
Journal Articles

Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort

Liyao Fu, Shi Tai, Jiaxing Sun, Ningjie Zhang, Ying Zhou, Zhenhua Xing, Yongjun Wang, Shenghua Zhou
Journal: Diabetes Care
Diabetes Care 2022;45(9):2136–2143
DOI: https://doi.org/10.2337/dc21-2511
Published: 14 July 2022
View article titled, Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
Open the PDF for Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort in another window
Journal Articles

Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study

Hertzel C. Gerstein, Sibylle Hess, Brian Claggett, Kenneth Dickstein, Lars Kober, Aldo P. Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean-Claude Tardif, Marc A. Pfeffer
Journal: Diabetes Care
Diabetes Care 2022;45(9):2152–2155
DOI: https://doi.org/10.2337/dc22-0453
Published: 11 July 2022
View article titled, Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study
Open the PDF for Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study in another window
Journal Articles

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study

Maximilian G. Posch, Niklas Walther, Ele Ferrannini, David R. Powell, Phillip Banks, Suman Wason, Raphael Dahmen
Journal: Diabetes Care
Diabetes Care 2022;45(9):2118–2126
DOI: https://doi.org/10.2337/dc21-2166
Published: 11 July 2022
View article titled, Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study
Open the PDF for Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study in another window
Journal Articles

Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45(Suppl. 1):S144–S174

American Diabetes Association Professional Practice Committee
Journal: Diabetes Care
Diabetes Care 2022;45(9):2178–2181
DOI: https://doi.org/10.2337/dc22-ad08
Published: 31 May 2022
View article titled, Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45(Suppl. 1):S144–S174
Open the PDF for Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45(Suppl. 1):S144–S174 in another window
Journal Articles

Response to Comment On Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552–2563

Ali Aminian, Steven E. Nissen
Journal: Diabetes Care
Diabetes Care 2022;45(5):e101
DOI: https://doi.org/10.2337/dci21-0061
Published: 05 May 2022
View article titled, Response to Comment On Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552–2563
Open the PDF for Response to Comment On Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552–2563 in another window
Journal Articles

Comment on Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552–2563

Jorge Rafael Violante-Cumpa, Raymundo Abram Sánchez-Gómez, Fernando Javier Lavalle-González, Leonardo Guadalupe Mancillas-Adame
Journal: Diabetes Care
Diabetes Care 2022;45(5):e100
DOI: https://doi.org/10.2337/dc21-2317
Published: 05 May 2022
View article titled, Comment on Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552–2563
Open the PDF for Comment on Aminian et al. Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care 2021;44:2552–2563 in another window
Journal Articles

Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study

Look AHEAD Research Group
Journal: Diabetes Care
Diabetes Care 2022;45(5):1252–1259
DOI: https://doi.org/10.2337/dc21-1805
Published: 21 March 2022
View article titled, Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study
Open the PDF for Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study in another window
Journal Articles

Admission Blood Glucose Level and Its Association With Cardiovascular and Renal Complications in Patients Hospitalized With COVID-19

Tom Norris, Cameron Razieh, Thomas Yates, Francesco Zaccardi, Clare L. Gillies, Yogini V. Chudasama, Alex Rowlands, Melanie J. Davies, Gerry P. McCann, Amitava Banerjee, Annemarie B. Docherty, Peter J.M. Openshaw, J. Kenneth Baillie, Malcolm G. Semple, Claire A. Lawson, Kamlesh Khunti
Journal: Diabetes Care
Diabetes Care 2022;45(5):1132–1140
DOI: https://doi.org/10.2337/dc21-1709
Published: 11 March 2022
View article titled, Admission Blood Glucose Level and Its Association With Cardiovascular and Renal Complications in Patients Hospitalized With COVID-19
Open the PDF for Admission Blood Glucose Level and Its Association With Cardiovascular and Renal Complications in Patients Hospitalized With COVID-19 in another window
Journal Articles

Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study

Peizhen Zhang, Dan Guo, Bingyan Xu, Chensihan Huang, Shunyu Yang, Weiwei Wang, Wenhui Liu, Yajuan Deng, Kangli Li, Deying Liu, Jiayang Lin, Xueyun Wei, Yan Huang, Huijie Zhang
Journal: Diabetes Care
Diabetes Care 2022;45(5):1219–1229
DOI: https://doi.org/10.2337/dc21-2193
Published: 28 February 2022
View article titled, Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study
Open the PDF for Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study in another window